ACRV
Acrivon Therapeutics, Inc. Common Stock
NASDAQHealthcareBiotechnologyUS
USD1.75
+0.01 (+0.57%)
Rating:B
Company Profile
CEO
Peter Blume-Jensen
IPO Date
2022-11-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$1.75
Prev. Close
$1.74
Day Low
$1.73
Day High
$1.77
52W Low
$1.20
52W High
$3.56
Market Cap
$0.06B
Volume
0.12M